However, in accordance with our previous findings [11], there was a significant positive association between CD38 expression levels on MM cells from patients and the efficacy of daratumumab to induce cell death (r = 0.38; p = 0.008) (Figure 2B). Here, CD38 is linked to Miyoshi myopathy.